永安药业
(002365)
| 流通市值：40.91亿 | | | 总市值：49.09亿 |
| 流通股本：2.46亿 | | | 总股本：2.95亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 234,835,187.73 | 267,439,688.6 | 211,651,545.97 | 320,405,292.96 |
| 交易性金融资产 | 687,313,267.01 | 663,569,139.75 | 690,646,230.75 | 600,160,393.06 |
| 应收票据及应收账款 | 134,815,540.67 | 127,341,534.62 | 141,114,835.18 | 160,680,293.89 |
| 其中：应收票据 | 10,316,592.96 | 14,812,468.14 | 10,979,043.41 | 6,712,910 |
| 应收账款 | 124,498,947.71 | 112,529,066.48 | 130,135,791.77 | 153,967,383.89 |
| 应收款项融资 | 4,113,500 | 250,000 | 200,000 | 1,106,263.2 |
| 预付款项 | 18,466,559.45 | 7,326,551.77 | 10,318,083.88 | 10,333,758.27 |
| 其他应收款合计 | 5,227,998.79 | 4,684,714.92 | 3,834,725.7 | 6,144,785.84 |
| 存货 | 78,413,956.41 | 100,619,312.68 | 90,319,474.84 | 93,502,681.55 |
| 其他流动资产 | 4,461,772.08 | 5,659,190.55 | 7,094,280.15 | 6,325,212.57 |
| 流动资产合计 | 1,167,647,782.14 | 1,176,890,132.89 | 1,155,179,176.47 | 1,198,658,681.34 |
| 非流动资产: | | | | |
| 长期股权投资 | 77,889,400.19 | 76,482,646.09 | 75,213,058.4 | 74,547,492.91 |
| 固定资产 | 898,275,188.84 | 902,878,924.94 | 861,000,721.49 | 881,816,043.56 |
| 在建工程 | 10,857,183.47 | 17,613,475.71 | 76,945,854.9 | 66,409,104.74 |
| 无形资产 | 77,728,091.22 | 78,596,442.57 | 79,450,782.53 | 79,559,070.1 |
| 递延所得税资产 | 8,844,564.9 | 7,603,299.38 | 6,577,279.94 | 5,839,916.81 |
| 其他非流动资产 | 21,188,663.08 | 6,521,652.9 | 1,216,935.66 | 1,772,596.39 |
| 非流动资产合计 | 1,094,783,091.7 | 1,089,696,441.59 | 1,100,404,632.92 | 1,109,944,224.51 |
| 资产总计 | 2,262,430,873.84 | 2,266,586,574.48 | 2,255,583,809.39 | 2,308,602,905.85 |
| 流动负债: | | | | |
| 短期借款 | 28,372,624.17 | 33,526,895.84 | 29,500,000 | 39,526,078.47 |
| 应付票据及应付账款 | 121,260,957.79 | 112,610,174.46 | 120,162,367.53 | 124,018,386.07 |
| 应付账款 | 121,260,957.79 | 112,610,174.46 | 120,162,367.53 | 124,018,386.07 |
| 合同负债 | 22,976,074.75 | 15,520,918.13 | 22,196,254.54 | 19,279,795.04 |
| 应付职工薪酬 | 31,933,224.23 | 27,204,352.52 | 24,290,218.37 | 38,857,601.21 |
| 应交税费 | 7,274,475.21 | 5,767,905.18 | 5,784,227.33 | 9,001,779.73 |
| 其他应付款合计 | 7,264,185.59 | 36,282,661.82 | 7,732,062.51 | 8,904,431.95 |
| 应付股利 | - | 28,914,515 | - | - |
| 其他流动负债 | 13,350,521.3 | 13,579,862.95 | 8,728,929.71 | 8,752,632.09 |
| 流动负债合计 | 232,432,063.04 | 244,492,770.9 | 218,394,059.99 | 248,340,704.56 |
| 非流动负债: | | | | |
| 递延收益 | 6,074,971.27 | 6,535,718.32 | 6,996,465.37 | 7,457,212.42 |
| 递延所得税负债 | 8,692,779.63 | 9,272,736.3 | 10,234,256.83 | 10,747,760.55 |
| 非流动负债合计 | 14,767,750.9 | 15,808,454.62 | 17,230,722.2 | 18,204,972.97 |
| 负债合计 | 247,199,813.94 | 260,301,225.52 | 235,624,782.19 | 266,545,677.53 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 294,682,500 | 294,682,500 | 294,682,500 | 294,682,500 |
| 资本公积 | 714,504,838.03 | 714,504,838.03 | 714,435,114.7 | 714,435,114.7 |
| 减:库存股 | 40,475,988.99 | 40,475,988.99 | 40,475,988.99 | 24,183,171.45 |
| 其他综合收益 | 2,314,983.54 | 2,370,011 | 2,391,184.39 | 2,401,801.91 |
| 专项储备 | 22,918,723.57 | 21,677,035.3 | 21,550,891.57 | 20,539,424.71 |
| 盈余公积 | 148,676,496.29 | 148,676,496.29 | 148,676,496.29 | 148,676,496.29 |
| 未分配利润 | 833,810,467.48 | 820,809,931.64 | 832,861,541.68 | 837,228,722.92 |
| 归属于母公司股东权益合计 | 1,976,432,019.92 | 1,962,244,823.27 | 1,974,121,739.64 | 1,993,780,889.08 |
| 少数股东权益 | 38,799,039.98 | 44,040,525.69 | 45,837,287.56 | 48,276,339.24 |
| 股东权益合计 | 2,015,231,059.9 | 2,006,285,348.96 | 2,019,959,027.2 | 2,042,057,228.32 |
| 负债和股东权益合计 | 2,262,430,873.84 | 2,266,586,574.48 | 2,255,583,809.39 | 2,308,602,905.85 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-29 | 2025-04-10 |
| 审计意见(境内) | | | | 标准无保留意见 |